✦ LIBER ✦

Progesterone Receptor Quantification as a Strong Prognostic Determinant in Postmenopausal Breast Cancer Women under Tamoxifen Therapy

✍ Scribed by Pierre-Jean Lamy; Pascal Pujol; Simon Thezenas; Andrew Kramar; Philippe Rouanet; Françoise Guilleux; Jean Grenier

Book ID: 110393659
Publisher: Springer US
Year: 2002
Tongue: English
Weight: 87 KB
Volume: 76
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1020228620173

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole versus tamoxifen as neoadjuv

Anastrozole versus tamoxifen as neoadjuvant therapy for oestrogen receptor-positive breast cancer in postmenopausal women: the IMPACT and PROACT trials

✍ I Smith; L Cataliotti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Randomised study of anastrozole versus t

Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women

✍ I. Vergote; J. Bonneterre; B. Thürlimann; J. Robertson; M. Krzakowski; L. Mauria 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Cost-Effectiveness of Letrozole Versus T

Cost-Effectiveness of Letrozole Versus Tamoxifen as Initial Adjuvant Therapy in Hormone Receptor–Positive Postmenopausal Women with Early-Stage Breast Cancer

✍ Thomas E. Delea; Jon Karnon; Oleg Sofrygin; Simu K. Thomas; Natalie L. Papo; Vic 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 194 KB

Efficacy of pre-operative Arimidex (anas

Efficacy of pre-operative Arimidex (anastrozole) compared with tamoxifen (PROACT) as neoadjuvant therapy in postmenopausal women with hormone receptor-positive breast cancer

✍ L Cataliotti; A Buzdar; S Noguchi; J Bines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br

Cost-effectiveness of letrozole versus t

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB